Bengaluru (Karnataka) [India], September 28 (ANI/BusinessWire India): UL, a global safety science company, today announced the launch of Bureau of Indian Standards (BIS) recognized testing services for heating, ventilation and air conditioning (HVAC) products as per the latest Indian Standar
New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
New Delhi [India], September 20 (ANI): The Drugs Controller General of India (DCGI) has given approval to the Tata Group for the launch of India's first Clustered Regularly Interspaced Short Palindromic (CRISPR) Covid-19 test for commercial launch.
New Delhi [India], September 19 (ANI): The Drug Controller General of India (DCGI), on Saturday gave approval for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) test, developed by the Tata Group and CSIR-IGIB (Institute of Genomics a
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.
New Delhi [India], September 3 (ANI): The Delhi High Court on Thursday permitted conducting breath analyser tests through tube process for air traffic controllers while allowing modification in its earlier order suspending the same in view of the COVID-19 pandemic.
Port Moresby (Papua New Guinea), August 21 (ANI): Papua New Guinea barred the arrival of a flight carrying Chinese workers after a Chinese mining company has claimed that it has immunised employees against COVID-19 in an apparent vaccination trial, authorities said on Friday.
Karachi [Pakistan], Aug 19 (ANI): A Pakistan International Airlines (PIA) flight coming from UAE to Peshawar on Wednesday made an emergency landing at Karachi International Airport after developing a technical fault, Pakistan media reported.